genedrive plc (LON:GDR – Get Free Report) shares traded up 8.4% during trading on Monday . The stock traded as high as GBX 0.80 and last traded at GBX 0.80. 5,946,840 shares were traded during trading, a decline of 70% from the average session volume of 20,072,496 shares. The stock had previously closed at GBX 0.74.
genedrive Price Performance
The company has a fifty day simple moving average of GBX 0.54 and a 200 day simple moving average of GBX 0.99. The stock has a market capitalization of £8.24 million, a price-to-earnings ratio of -0.37 and a beta of -0.04. The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.52 and a current ratio of 4.60.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Further Reading
- Five stocks we like better than genedrive
- 3 Tickers Leading a Meme Stock Revival
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- Basic Materials Stocks Investing
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- How to buy stock: A step-by-step guide for beginners
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
